The Worst Drug Company Marketing Techniques (V): SCHERING-PLOUGH

The New Jersey-based drug company Schering-Plough Corp. was charged with marketing two cancer drugs, Temodar and Intron A, for unapproved uses. The government alleged that Schering-Plough salespeople falsely claimed that Temodar had been approved by the FDA to treat brain tumors, and despite censure from the FDA, the company continued to illegally promote the drugs. In 2006, the company, which has since been acquired by Merck, settled the case for $435 million.

Ver anteriores...